Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |